(1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one

C35H32BrN9O4 — CID 153306552

IUPAC(1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one
SMILESC=C1COCc2ccc(Br)nc2NC(=O)[C@@H]2C[C@]3(C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(-c4cnc(C)nc4)ccc32)Cn2cc1cn2
InChIInChI=1S/C35H32BrN9O4/c1-19-16-49-17-23-5-7-30(36)40-33(23)41-34(48)28-9-35(18-43-14-25(19)13-39-43)10-29(35)45(28)31(47)15-44-27-6-4-22(24-11-37-21(3)38-12-24)8-26(27)32(42-44)20(2)46/h4-8,11-14,28-29H,1,9-10,15-18H2,2-3H3,(H,40,41,48)/t28-,29+,35-/m0/s1
InChIKeyKRXPITACUMSKFU-AXJWHKOCSA-N
MW722.60 g/mol
LogP4.60
Rot. Bonds4

About (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one

(1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one (PubChem CID 153306552) has the molecular formula C35H32BrN9O4 and a molecular weight of 722.60 g/mol. Its IUPAC name is (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one.

Molecular Properties

Compound Name(1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one
PubChem CID153306552
Molecular FormulaC35H32BrN9O4
Molecular Weight722.60 g/mol
Exact Mass721.18
IUPAC Name(1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one
SMILESC=C1COCc2ccc(Br)nc2NC(=O)[C@@H]2C[C@]3(C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(-c4cnc(C)nc4)ccc32)Cn2cc1cn2
InChIInChI=1S/C35H32BrN9O4/c1-19-16-49-17-23-5-7-30(36)40-33(23)41-34(48)28-9-35(18-43-14-25(19)13-39-43)10-29(35)45(28)31(47)15-44-27-6-4-22(24-11-37-21(3)38-12-24)8-26(27)32(42-44)20(2)46/h4-8,11-14,28-29H,1,9-10,15-18H2,2-3H3,(H,40,41,48)/t28-,29+,35-/m0/s1
InChIKeyKRXPITACUMSKFU-AXJWHKOCSA-N
XLogP4.60
TPSA150.02 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds4
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500722.60
LogP ≤ 54.60
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one?
The IUPAC name of (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one (CID 153306552) is (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one.
What is the SMILES notation for (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one?
The canonical SMILES for (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one is C=C1COCc2ccc(Br)nc2NC(=O)[C@@H]2C[C@]3(C[C@H]3N2C(=O)Cn2nc(C(C)=O)c3cc(-c4cnc(C)nc4)ccc32)Cn2cc1cn2.
What is the InChIKey of (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one?
The InChIKey is KRXPITACUMSKFU-AXJWHKOCSA-N. The full InChI is InChI=1S/C35H32BrN9O4/c1-19-16-49-17-23-5-7-30(36)40-33(23)41-34(48)28-9-35(18-43-14-25(19)13-39-43)10-29(35)45(28)31(47)15-44-27-6-4-22(24-11-37-21(3)38-12-24)8-26(27)32(42-44)20(2)46/h4-8,11-14,28-29H,1,9-10,15-18H2,2-3H3,(H,40,41,48)/t28-,29+,35-/m0/s1.
What are the key properties of (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one?
(1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one has a molecular weight of 722.60 g/mol, XLogP of 4.60, 4 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-7-methylidene-9-oxa-3,4,15,17,20-pentazapentacyclo[17.3.1.13,6.01,21.011,16]tetracosa-4,6(24),11(16),12,14-pentaen-18-one is sourced from PubChem (CID 153306552), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).